Placeholder Banner

BIO Files Amicus Brief on Case Addressing the America Invents Act’s Joinder Provision

December 28, 2018

BIO filed an amicus brief in Proppant Express Investments, LLC, Proppant Express Solutions, LLC, v. Oren Technologies, LLC in front of the Patent Trial and Appeal Board.

BIO members devote billions of dollars annually to researching and developing biotechnological healthcare, agricultural, environmental, and industrial products to cure diseases, improve food security, create alternative energy sources, and deliver many other benefits. However, these products typically require lengthy, costly, and resource-intensive research and development.

In light of these investments, BIO’s members depend upon a stable, predictable, and transparent patent system encouraging patent-holders to maintain and enforce strong patents. In particular, BIO’s members have a significant interest in ensuring the America Invents Act’s joinder provision, 35 U.S.C. § 315(c), is interpreted as Congress intended, and that only proper parties can join an existing inter partes review (IPR) proceeding.

Related Resources
IPR2018-00914 - Amicus Brief By BIO
Proppant Express Investments vs. Oren Technologies (BIO Brief as Amicus Curiae)
Discover More
BIO filed an amicus brief in the Supreme Court of the State of Delaware, urging the Court to exclude Plaintiffs’ expert opinion, thereby ensuring that Delaware’s standard for the admission of such evidence remains consistent with the federal …
On February 10, 2025, BIO filed an amicus brief in the U.S. District Court for the District of Columbia, supporting the lawfulness of plaintiff Eli Lilly's proposed 340B rebate model. The 340B Drug Pricing Program ("340B"), through which Medicaid…
BIO filed an amicus brief in the U.S. Court of Appeals for the Federal Circuit urging rehearing of a case involving whether certain Teva Pharmaceuticals patents had been properly listed in FDA’s Orange Book (Approved Drug Products with Therapeutic…